Condition: Multiple Myeloma · Sponsor: Pfizer
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab Parent Studies.
This description comes directly from the study's public registry record.
Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| UCI Health - Irvine Infusion Pharmacy ACC | Irvine, California, United States | Recruiting |
| UC Irvine Health | Orange, California, United States | Recruiting |
| UCI Health | Orange, California, United States | Recruiting |
| UCHealth Poudre Valley Hospital | Fort Collins, Colorado, United States | Recruiting |
| UCHealth Harmony | Fort Collins, Colorado, United States | Recruiting |
| UCHealth Greeley Hospital | Greeley, Colorado, United States | Recruiting |
| Longs Peak Hospital | Longmont, Colorado, United States | Recruiting |
| UCHealth Longs Peak Medical Center | Longmont, Colorado, United States | Recruiting |
| UCHealth - Medical Center of the Rockies | Loveland, Colorado, United States | Recruiting |
| Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center | Coral Gables, Florida, United States | Recruiting |
| University of Miami Hospital and Clinics Deerfield Beach | Deerfield Beach, Florida, United States | Recruiting |
| Sylvester Comprehensive Cancer Center | Miami, Florida, United States | Recruiting |
+ 21 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06057402